Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
PUT
Dorian LPG
LPG
$2.17B
| $592K | ﹤0.01% |
26,500
-4,400
| -14% | -$102K |
|
2177
RPM International
RPM
$13.6B
| $590K | ﹤0.01% |
+5,101
| New | +$620K |
|
2178
Neuropace
NPCE
$486M
| $590K | ﹤0.01% |
+48,010
| New | +$601K |
|
2179
SolarEdge
SEDG
$1.84B
| $589K | ﹤0.01% |
36,424
-85,185
| -70% | -$1.32M |
|
2180
CALL
Lincoln National
LNC
$8.16B
| $589K | ﹤0.01% |
+16,400
| New | +$582K |
|
2181
CALL
Cameco
CCJ
$46.6B
| $589K | ﹤0.01% |
14,300
-85,900
| -86% | -$4.04M |
|
2182
PUT
Intercontinental Exchange
ICE
$90.8B
| $587K | ﹤0.01% |
3,400
-4,200
| -55% | -$688K |
|
2183
PUT
Kenvue
KVUE
$37.1B
| $585K | ﹤0.01% |
+24,400
| New | +$540K |
|
2184
Pebblebrook Hotel Trust
PEB
$2.07B
| $585K | ﹤0.01% |
57,703
-270,965
| -82% | -$3.32M |
|
2185
Ocular Therapeutix
OCUL
$2.39B
| $584K | ﹤0.01% |
+79,648
| New | +$612K |
|
2186
PUT
Howmet Aerospace
HWM
$105B
| $584K | ﹤0.01% |
4,500
-20,600
| -82% | -$2.62M |
|
|
FL
2187
PUT
DELISTED
Foot Locker
FL
| $584K | ﹤0.01% |
41,400
+1,000
| +2% | +$18.5K |
|
2188
PUT
MasTec
MTZ
$19.8B
| $584K | ﹤0.01% |
+5,000
| New | +$675K |
|
2189
WisdomTree India Earnings Fund ETF
EPI
$2.05B
| $583K | ﹤0.01% |
13,327
-8,450
| -39% | -$362K |
|
|
FOLD
2190
DELISTED
Amicus Therapeutics
FOLD
| $582K | ﹤0.01% |
71,291
-77,577
| -52% | -$718K |
|
2191
PUT
Pinduoduo
PDD
$125B
| $580K | ﹤0.01% |
4,900
-130,600
| -96% | -$15M |
|
|
SFIX
2192
Stitch Fix
SFIX
$423M
| $579K | ﹤0.01% |
+178,197
| New | +$812K |
|
2193
Immersion
IMMR
$254M
| $576K | ﹤0.01% |
75,991
-4,138
| -5% | -$33.9K |
|
|
MFA
2194
MFA Financial
MFA
$894M
| $574K | ﹤0.01% |
+55,983
| New | +$586K |
|
2195
PUT
EPAM Systems
EPAM
$5.77B
| $574K | ﹤0.01% |
+3,400
| New | +$750K |
|
2196
Western Digital
WDC
$163B
| $573K | ﹤0.01% |
+14,165
| New | +$672K |
|
2197
PUT
Insmed
INSM
$27.1B
| $572K | ﹤0.01% |
7,500
-13,000
| -63% | -$994K |
|
2198
PUT
Marriott International
MAR
$93.3B
| $572K | ﹤0.01% |
+2,400
| New | +$652K |
|
2199
PUT
CF Industries
CF
$19.3B
| $570K | ﹤0.01% |
7,300
-419,400
| -98% | -$35.2M |
|
2200
Schwab U.S Small- Cap ETF
SCHA
$22.9B
| $569K | ﹤0.01% |
+24,303
| New | +$619K |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.